Our NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock (0831042) is designed to evaluate the performance of nucleic acid testsfor determination of the presence of SARS-CoV-2 E gene and portions of the ORF1ab generegion. NATtrol™ SARS-CoV-2 (E/ORF1ab recombinant) Stock can also be used for validation of clinical assays, development of diagnostic testsand training of laboratory personnel.
Our NATtrol™ SARS-CoV-2 (recombinant) Stock (0831043) is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. NATtrol™ SARS-CoV-2 (recombinant) Stock can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.